Anti-PD-L1 monotherapy also showed a trend of upregulation of this program.
← all excerpts
Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors.
1
—
—
Anti-PD-L1 monotherapy also showed a trend of upregulation of this program.